Office of Technology Transfer
SIU-SOM Available Technologies
The SIU-SOM Office of Technology Transfer has developed a diverse patent and intellectual property portfolio with technologies in several key areas such as: novel therapeutics for cancer treatment toxicities, DNA/RNA research tools, antibodies, tinnitus testing, biomarkers, vaccines, and more. Please click on one of the links below to access a non-confidential summary and contact information for a specific technology. For information on developing these technologies and others not listed on this page, please contact Robert Patino at (217) 545-8168 or rpatino@siumed.edu.
Drugs, Therapeutics and Diagnostics
- Antimicrobial Peptides and Methods of Use
- The Use of Transplatin in Hearing Loss
- ARL-1 Specific Antibodies and ARL-1 Biomarker
- Therapeutic Use of Methionine to Reduce the Toxicity of Aminoglycoside Antibiotics
- Therapeutic Use of Methionine to Reduce the Toxicity of Platinum-Containing Anti-Tumor Compounds
- Therapeutic Use of Methionine for the Treatment or Prevention of Mucositis
- Therapeutic Use of Methionine to Reduce the Toxicity of Noise
- Effective Genital Herpes Vaccine
Research Tools and Miscellaneous Technologies
- A Genetic Selection System for Identification of microRNA Target Genes
- Picture Memory Recognition Test for Dementia Patients